CONCLUSIONS : No association between the IL-1beta polymorphisms and the TAO existed , so those polymorphisms are not suitable genetic markers for TAO.
Genotype frequencies and IL-1beta serum levels were not significantly different between the study group and the control group.
BACKGROUND : Elevated serum levels of interleukin-1 beta (IL-1beta) have been previously observed in patients with oral cancer.
These findings are in accordance with previously observed high TNF-alpha levels in serum of patients with oral cancer in comparison to healthy controls.
Apoptosis was blocked by caspase inhibitors , and TNF-alpha treatment led to activation of caspase-2 , caspase-3 , and caspase-8 only when NF-kappaB activation was blocked.
AP-1 and NF-kappaB are rapidly activated during liver regeneration.